Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$12.99 - $16.48 $1.81 Million - $2.3 Million
-139,355 Reduced 46.63%
159,495 $2.23 Million
Q4 2022

Feb 09, 2023

BUY
$12.5 - $24.78 $3.21 Million - $6.36 Million
256,850 Added 611.55%
298,850 $4.28 Million
Q3 2022

Nov 10, 2022

SELL
$20.6 - $30.37 $2,183 - $3,219
-106 Reduced 0.25%
42,000 $1.07 Million
Q2 2022

Aug 08, 2022

BUY
$26.05 - $37.48 $1.1 Million - $1.58 Million
42,106 New
42,106 $1.19 Million
Q4 2021

Feb 11, 2022

SELL
$35.0 - $45.94 $7.38 Million - $9.69 Million
-210,900 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$36.8 - $60.62 $7.76 Million - $12.8 Million
210,900 New
210,900 $10.2 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $738M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.